Trial Profile
Achieving appropriate exposuRe to RIBAvirin after a dose advise based on an abbreviated AUC of a first dose of ribavirin (ARRIBA)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Apr 2022
Price :
$35
*
At a glance
- Drugs Ribavirin (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics; Therapeutic Use
- Acronyms ARRIBA
- 06 Apr 2022 Status changed from recruiting to completed.
- 23 Jun 2011 New trial record